Key points are not available for this paper at this time.
Bronchopulmonary dysplasia (BPD) is the most common long-term respiratory morbidity affecting very preterm infants and has a negative impact on future lung function and quality of life. BPD management during a neonatal intensive care unit (NICU) stay is mainly based on a set of preventive measures. Despite improvements in pharmacological and non-pharmacological research, only a few therapeutic measures available are supported by high-quality evidence. This review essentially focuses on preventive and therapeutic options for preterm neonates at risk of, or with established, BPD, during their NICU stay.
Gustavo Rocha (Mon,) studied this question.